The awardees are Daniel Drucker, an endocrinologist at the University of Toronto, Joel Habener, an endocrinologist at Harvard Medical School, Jens Juul Holst, a physiologist at the University of Copenhagen, Lotte Bjerre Knudsen, a pharmaceutical scientist at Novo Nordisk, and Svetlana Mojsov, a chemist at The Rockefeller University
Common Side Effects and How to Manage Them GLP-1 medications are generally well-tolerated when used under medical supervision, but side effects - particularly gastrointestinal effects - are common, especially during the early weeks and after dose increases
Furthermore, the study cohort included individuals who either switched to or added on treatment with other glucose-lowering drugs
Consistency Across Diverse Populations What makes these results particularly noteworthy